Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NPS up after Nycomed affirms Gattex plans

NPSP gained $0.71 (18%) to $4.56 on Wednesday after Nycomed

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE